FDA rejects Sydnexis’ myopia drug for kids; Chugai to buy Renalys for $98M upfront

Plus, news about Kura Oncology, X4 Pharmaceuticals, Coya Therapeutics, Harbour BioMed and Silver Creek: 👁️ FDA rejects Sydnexis’ experimental myopia drug: The company said the regulator does not believe the data ...